The CFTC greenlit the first U.S. bitcoin perpetual futures, rebuffing CME Group's legal opposition and signaling a shift in the regulatory landscape for crypto derivatives.
Bitcoin is positioned for significant market expansion following the CFTC's approval of its first bitcoin perpetual futures product. This regulatory milestone provides a new avenue for institutional and retail participation in the U.S. market, despite ongoing legal challenges from established exchange operators.
It marks the first time a bitcoin perpetual futures product has been authorized for the U.S. market, signaling a shift in regulatory stance.
CME faces a strategic setback as the CFTC has rebuffed its legal challenge against the approval of new bitcoin perpetual futures. The agency's argument that CME failed to demonstrate tangible harm from the new policy weakens the exchange's position in protecting its derivatives market share.
The CFTC argues that CME has not provided sufficient evidence to show that the new bitcoin perpetual futures policy is causing actual harm to its business.
The Commodity Futures Trading Commission has officially approved the first bitcoin perpetual futures product in the U.S. market. The regulator dismissed legal challenges from CME Group, arguing the exchange failed to demonstrate that the new policy causes material competitive harm to its existing derivatives business.
The CFTC argued that CME Group failed to provide sufficient evidence that the approval of the new bitcoin perpetual futures product would cause them direct competitive harm.
This approval introduces the first regulated bitcoin perpetual futures to the U.S. market, expanding the range of available crypto-based derivatives.